July 2025
1. PICCOLO R, Laino A, Vitale AP, Franzone A, et al
   Sex related differences in efficacy and safety of antithrombotic therapy in patients with coronary artery disease: systematic review and meta-analysis.
   BMJ. 2025;390:e082974.
   

   >> Share

   
   
2. CHEN C, Zhou W, Cui Y, Cao K, et al
   Global, regional, and national characteristics of the main causes of increased disease burden due to the covid-19 pandemic: time-series modelling analysis of global burden of disease study 2021.
   BMJ. 2025;390:e083868.
   

   >> Share

   
   June 2025
3. FENG J, Hu R, Lyu M, Ma X, et al
   Right C7 neurotomy at the intervertebral foramen plus intensive speech and language therapy versus intensive speech and language therapy alone for chronic post-stroke aphasia: multicentre, randomised controlled trial.
   BMJ. 2025;389:e083605.
   

   >> Share

   
   
4. GIACOPPO D, Gragnano F, Watanabe H, Kimura T, et al
   P2Y(12) inhibitor or aspirin after percutaneous coronary intervention: individual patient data meta-analysis of randomised clinical trials.
   BMJ. 2025;389:e082561.
   

   >> Share

   
   May 2025
5. SHARMA R, Lee K
   Advances in treatments for acute ischemic stroke.
   BMJ. 2025;389:e076161.
   

   >> Share

   
   March 2025
6. GAO C, Zhu B, Ouyang F, Wen S, et al
   Stepwise dual antiplatelet therapy de-escalation in patients after drug coated balloon angioplasty (REC-CAGEFREE II): multicentre, randomised, open label, assessor blind, non-inferiority trial.
   BMJ. 2025;388:e082945.
   

   >> Share

   
   
7. JURASCHEK SP, Hu JR, Cluett JL, Mita C, et al
   Effects of intensive blood pressure treatment on orthostatic hypertension: individual level meta-analysis.
   BMJ. 2025;388:e080507.
   

   >> Share

   
   
8. SKOLOUDIK D, Hrbac T, Kovar M, Benes V 3rd, et al
   Sonolysis during carotid endarterectomy: randomised controlled trial.
   BMJ. 2025;388:e082750.
   

   >> Share

   
   
9. ANAND SS, Bosch J, Mehran R, Mehta SR, et al
   Designing inclusive clinical trials: how researchers can drive change to improve diversity.
   BMJ. 2025;388:e082485.
   

   >> Share

   
   
10. ANAND SS, Arbour L, Ogilvie GS, Tita ATN, et al
    Inclusive research: a path to equity and better outcomes.
    BMJ. 2025;388:e082486.
    

    >> Share

    
    February 2025
11. YONIS H, Lokkegaard E, Kragholm K, Granger CB, et al
    Stroke and myocardial infarction with contemporary hormonal contraception: real-world, nationwide, prospective cohort study.
    BMJ. 2025;388:e082801.
    

    >> Share

    
    January 2025
12. HU W, Tao C, Wang L, Chen Z, et al
    Intra-arterial tenecteplase after successful endovascular recanalisation in patients with acute posterior circulation arterial occlusion (ATTENTION-IA): multicentre randomised controlled trial.
    BMJ. 2025;388:e080489.
    

    >> Share

    
    
13. OZANNE EM, Barnes GD, Brito JP, Cameron KA, et al
    Effectiveness of shared decision making strategies for stroke prevention among patients with atrial fibrillation: cluster randomized controlled trial.
    BMJ. 2025;388:e079976.
    

    >> Share

    
    November 2024
14. SVANSTROM H, Mkoma GF, Hviid A, Pasternak B, et al
    SGLT-2 inhibitors and mortality among patients with heart failure with reduced ejection fraction: linked database study.
    BMJ. 2024;387:e080925.
    

    >> Share

    
    October 2024
15. NOLAN T
    Anticoagulants after acute ischaemic stroke ... and other research.
    BMJ. 2024;387:q2378.
    

    >> Share

    
    
16. KHAN F, Meinel T, Lun R, Yu AYX, et al
    Should patients treated with direct oral anticoagulants receive intravenous thrombolytics for acute ischaemic stroke?
    BMJ. 2024;387:e079322.
    

    >> Share

    
    
17. OKPECHI IG, Levin A, Tungsanga S, Arruebo S, et al
    Progress of nations in the organisation of, and structures for, kidney care delivery between 2019 and 2023: cross sectional survey in 148 countries.
    BMJ. 2024;387:e079937.
    

    >> Share

    
    
18. AGARWAL A, Zeng X, Li S, Rayner D, et al
    Sodium-glucose cotransporter-2 (SGLT-2) inhibitors for adults with chronic kidney disease: a clinical practice guideline.
    BMJ. 2024;387:e080257.
    

    >> Share

    
    September 2024
19. LOOI MK
    From one neurologist to one unit: turning the tide against stroke in Malawi.
    BMJ. 2024;386:q1968.
    

    >> Share

    
    June 2024
20. LI J, Meng X, Shi FD, Jing J, et al
    Colchicine in patients with acute ischaemic stroke or transient ischaemic attack (CHANCE-3): multicentre, double blind, randomised, placebo controlled trial.
    BMJ. 2024;385:e079061.
    

    >> Share

    
    
21. CONRAD N, Molenberghs G, Verbeke G, Zaccardi F, et al
    Trends in cardiovascular disease incidence among 22 million people in the UK over 20 years: population based study.
    BMJ. 2024;385:e078523.
    

    >> Share

    
    
22. SCHIFFRIN EL, Fisher NDL
    Diagnosis and management of resistant hypertension.
    BMJ. 2024;385:e079108.
    

    >> Share

    
    
23. ZHU Y, Zhang W, Dimagli A, Han L, et al
    Antiplatelet therapy after coronary artery bypass surgery: five year follow-up of randomised DACAB trial.
    BMJ. 2024;385:e075707.
    

    >> Share

    
    
24. SANDNER S
    Dual antiplatelet therapy after coronary artery bypass surgery.
    BMJ. 2024;385:q1083.
    

    >> Share

    
    April 2024
25. SIMMS-WILLIAMS N, Treves N, Yin H, Lu S, et al
    Effect of combination treatment with glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors on incidence of cardiovascular and serious renal events: population based cohort study.
    BMJ. 2024;385:e078242.
    

    >> Share

    
    
26. MOK PLH, Carr MJ, Guthrie B, Morales DR, et al
    Multiple adverse outcomes associated with antipsychotic use in people with dementia: population based matched cohort study.
    BMJ. 2024;385:e076268.
    

    >> Share

    
    
27. VINTER N, Cordsen P, Johnsen SP, Staerk L, et al
    Temporal trends in lifetime risks of atrial fibrillation and its complications between 2000 and 2022: Danish, nationwide, population based cohort study.
    BMJ. 2024;385:e077209.
    

    >> Share

    
    March 2024
28. KAVIRAJ C
    Caring is the invisible piece of the stroke recovery puzzle.
    BMJ. 2024;384:q286.
    

    >> Share

    
    
29. CROCKER TF, Ensor J, Lam N, Jordao M, et al
    Community based complex interventions to sustain independence in older people: systematic review and network meta-analysis.
    BMJ. 2024;384:e077764.
    

    >> Share

    
    
30. NOLAN T
    The impact of response times on effect of thrombolysis and other research.
    BMJ. 2024;384:q601.
    

    >> Share

    
    
31. SAUL H, Deeney B, Swaithes L, Hounkpatin H, et al
    Even short periods of diabetes remission are linked to lower risk of heart attack and stroke.
    BMJ. 2024;384:q516.
    

    >> Share

    
    February 2024
32. KMIETOWICZ Z
    Sponge-on-a-string test replaces need for endoscopy in eight in 10 reflux patients.
    BMJ. 2024;384:q501.
    

    >> Share

    
    
33. KIM KS, Hong S, Han K, Park CY, et al
    Association of non-alcoholic fatty liver disease with cardiovascular disease and all cause death in patients with type 2 diabetes mellitus: nationwide population based study.
    BMJ. 2024;384:e076388.
    

    >> Share

    
    
34. MAHASE E
    Variability in blood pressure could help predict heart attack and stroke risk, researchers say.
    BMJ. 2024;384:q363.
    

    >> Share

    
    January 2024
35. 
    Ticagrelor plus aspirin versus clopidogrel plus aspirin for platelet reactivity in patients with minor stroke or transient ischaemic attack: open label, blinded endpoint, randomised controlled phase II trial.
    BMJ. 2024;384:q131.
    

    >> Share

    
    November 2023
36. LELIEVELD J, Haines A, Burnett R, Tonne C, et al
    Air pollution deaths attributable to fossil fuels: observational and modelling study.
    BMJ. 2023;383:e077784.
    

    >> Share

    
    
37. KHAN SU, Agarwal S, Arshad HB, Akbar UA, et al
    Intravascular imaging guided versus coronary angiography guided percutaneous coronary intervention: systematic review and meta-analysis.
    BMJ. 2023;383:e077848.
    

    >> Share

    
    
38. SAUL H, Cassidy S, Deeney B, Imison C, et al
    Early, intense therapy for language problems after a stroke is linked to the greatest benefits.
    BMJ. 2023;383:p2560.
    

    >> Share

    
    October 2023
39. ILIEVA H, Vullaganti M, Kwan J
    Advances in molecular pathology, diagnosis, and treatment of amyotrophic lateral sclerosis.
    BMJ. 2023;383:e075037.
    

    >> Share

    
    
40. LEE YJ, Hong SJ, Kang WC, Hong BK, et al
    Rosuvastatin versus atorvastatin treatment in adults with coronary artery disease: secondary analysis of the randomised LODESTAR trial.
    BMJ. 2023;383:e075837.
    

    >> Share

    
    
41. MAHASE E
    Stroke patients should be offered at least 15 hours of rehabilitation a week, NICE advises.
    BMJ. 2023;383:p2417.
    

    >> Share

    
    
42. OXTOBY K
    Calm under pressure: the stroke physician.
    BMJ. 2023;383:p2123.
    

    >> Share

    
    
43. LIU L, Xie X, Pan Y, Wang A, et al
    Early versus delayed antihypertensive treatment in patients with acute ischaemic stroke: multicentre, open label, randomised, controlled trial.
    BMJ. 2023;383:e076448.
    

    >> Share

    
    
44. RIMMER A
    GP's mistakes led to patient losing sight after a stroke, says ombudsman.
    BMJ. 2023;383:p2306.
    

    >> Share

    
    September 2023
45. HOLMBERG D, Santoni G, von Euler-Chelpin M, Farkkila M, et al
    Non-erosive gastro-oesophageal reflux disease and incidence of oesophageal adenocarcinoma in three Nordic countries: population based cohort study.
    BMJ. 2023;382:e076017.
    

    >> Share

    
    August 2023
46. BROWN RL, Benjamin L, Lunn MP, Bharucha T, et al
    Pathophysiology, diagnosis, and management of neuroinflammation in covid-19.
    BMJ. 2023;382:e073923.
    

    >> Share

    
    June 2023
47. THOMPSON B, Waterhouse M, English DR, McLeod DS, et al
    Vitamin D supplementation and major cardiovascular events: D-Health randomised controlled trial.
    BMJ. 2023;381:e075230.
    

    >> Share

    
    
48. GALE CP, Stocken DD, Aktaa S, Reynolds C, et al
    Effectiveness of GRACE risk score in patients admitted to hospital with non-ST elevation acute coronary syndrome (UKGRIS): parallel group cluster randomised controlled trial.
    BMJ. 2023;381:e073843.
    

    >> Share

    
    May 2023
49. KMIETOWICZ Z
    Stroke: Take test for genetic variant to ensure clopidogrel works for prevention, says NICE.
    BMJ. 2023;381:p1146.
    

    >> Share

    
    April 2023
50. SHI Q, Nong K, Vandvik PO, Guyatt GH, et al
    Benefits and harms of drug treatment for type 2 diabetes: systematic review and network meta-analysis of randomised controlled trials.
    BMJ. 2023;381:e074068.
    

    >> Share

    
    March 2023
51. KARAM G, Agarwal A, Sadeghirad B, Jalink M, et al
    Comparison of seven popular structured dietary programmes and risk of mortality and major cardiovascular events in patients at increased cardiovascular risk: systematic review and network meta-analysis.
    BMJ. 2023;380:e072003.
    

    >> Share

    
    
52. MORALES DR, Minchin M, Kontopantelis E, Roland M, et al
    Estimated impact from the withdrawal of primary care financial incentives on selected indicators of quality of care in Scotland: controlled interrupted time series analysis.
    BMJ. 2023;380:e072098.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share